Stockscreener 앱 받기
1.55
9.93%
0.14
전일 마감가:
$1.41
열려 있는:
$1.41
하루 거래량:
321.30K
Relative Volume:
1.05
시가총액:
$2.23M
수익:
$4.70M
순이익/손실:
$-4.99M
주가수익비율:
-0.1209
EPS:
-12.82
순현금흐름:
$-5.29M
1주 성능:
+5.45%
1개월 성능:
+10.71%
6개월 성능:
-44.92%
1년 성능:
-68.75%
1일 변동 폭
$1.28
$1.60
1주일 범위
$1.22
$1.62
52주 변동 폭
$1.22
$7.20
Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile
명칭
Salarius Pharmaceuticals Inc
전화
346-772-0346
주소
2450 HOLCOMBE BLVD, HOUSTON
SLRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLRX
Salarius Pharmaceuticals Inc
|
1.55 | 2.23M | 4.70M | -4.99M | -5.29M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-04-27 | 개시 | Ladenburg Thalmann | Buy |
Salarius Pharmaceuticals Inc 주식(SLRX)의 최신 뉴스
SLRX stock touches 52-week low at $1.24 amid market challenges - Investing.com
Salarius Pharmaceuticals, Inc. announced that it expects to receive $10 million in funding - Marketscreener.com
Salarius Pharmaceuticals Inc (SLRX) Quarterly 10-Q Report - Quartzy
Salarius: Q3 Earnings Snapshot - Houston Chronicle
Salarius Pharmaceuticals (FRA:FP10) Intrinsic Value: Projec - GuruFocus.com
SLRX Stock Update: Salarius Pharmaceuticals Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
SLRX stock touches 52-week low at $1.3 amid market challenges - Investing.com India
SLRX stock touches 52-week low at $1.34 amid market challenges - Investing.com India
SLRX stock touches 52-week low at $1.34 amid market challenges By Investing.com - Investing.com South Africa
Salarius Pharmaceuticals sets date for 2024 Annual Meeting By Investing.com - Investing.com Canada
Salarius Pharmaceuticals (NASDAQ:SLRX) Stock Quotes, Forecast and News Summary - Benzinga
Salarius Pharmaceuticals sets date for 2024 Annual Meeting - Investing.com
Sasol Limited (SSL): Among the Worst Affordable Stocks to Buy Under $10 - Yahoo Finance UK
Ready to Jump After Recent Trade: SELLAS Life Sciences Group Inc (SLS) - SETE News
2,100 Shares in Silicon Laboratories Inc. (NASDAQ:SLAB) Bought by MQS Management LLC - Defense World
Rhumbline Advisers Makes New Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Silence Therapeutics plc (NASDAQ:SLN) is M28 Capital Management LP's 6th Largest Position - MarketBeat
Strategic Education, Inc. (NASDAQ:STRA) Holdings Raised by Dimensional Fund Advisors LP - Defense World
Safire Group Raises $8M in Financing - FinSMEs
Drugmaker for rare disease soars 1,200% in last year - Kursiv Media
Soleno Therapeutics (NASDAQ:SLNO) Reaches New 52-Week High at $54.32 - MarketBeat
Saala gets an OTT release date - Cinema Express
Salarius Pharmaceuticals (NASDAQ:SLRX) Trading Up 0.7% - Defense World
Salarius Pharmaceuticals registers new shares for offering By Investing.com - Investing.com Australia
Salarius Pharmaceuticals registers new shares for offering - Investing.com India
SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q2 2024 - InvestorPlace
The Future of Salarius Pharmaceuticals Inc: Analyzing SLRX - The InvestChronicle
Salarius: Q2 Earnings Snapshot - San Antonio Express-News
Salarius Pharmaceuticals Inc (SLRX)’s Day in Review: Closing at 2.06, Down by -12.71 - The Dwinnex
Take off with Salarius Pharmaceuticals Inc (SLRX): Get ready for trading - SETE News
The Significance of Moving Averages in Salarius Pharmaceuticals Inc Inc. (SLRX) Price Performance - The InvestChronicle
Understanding SLRX stock ratios for better investment decisions - US Post News
Market Insights: Salarius Pharmaceuticals Inc (SLRX)’s Notable Drop of -11.53, Closing at 3.30 - The Dwinnex
Salarius Pharmaceuticals Inc [SLRX] Revenue clocked in at $0.00 million, down -28.27% YTD: What’s Next? - The DBT News
Salarius Pharmaceuticals Inc (SLRX Stock: A Sea of Opportunity - The InvestChronicle
Market Insights: Salarius Pharmaceuticals Inc (SLRX)’s Notable Gain of 63.55, Closing at 3.50 - The Dwinnex
Salarius Pharmaceuticals Registers New Stock Offering By Investing.com - Investing.com Canada
Salarius Pharmaceuticals Registers New Stock Offering - Investing.com
Pieris Pharmaceuticals ($PIRS) and Palvella Therapeutics Announce Exciting Merger - BP Journal
Holdings of Salarius Pharmaceuticals Inc (SLRX) are aligned with the stars - SETE News
Salarius Pharmaceuticals (SLRX) drops 21% and here’s why - BP Journal
Azitra (AZTR) Makes Strides with New Patents and Public Offering - BP Journal
Why Is Salarius Pharmaceuticals (SLRX) Stock Up 90% Today? - InvestorPlace
Salarius Pharmaceuticals registers new stock offering - Investing.com India
Salarius Pharmaceuticals registers new stock offering By Investing.com - Investing.com Canada
Salarius Pharmaceuticals Inc (SLRX) is a good investment, but the stock may be undervalued - US Post News
MEIP Stock sees a Significant Surge Amidst Strategic Evaluation - BP Journal
Will MIRA Pharmaceuticals MIRA Stock Keep Surging further on Promising Preclinical Data for Ketamir-2 - BP Journal
Salarius Pharmaceuticals Inc Inc. (SLRX) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Salarius Pharmaceuticals Inc (SLRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):